FDA Statement on Iressa for patients with lung cancer
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival
690441
NEW YORK  - Having isolated arthritis in one knee could be an early warning sign for lung cancer, Italian researchers suggest.
619726
AstraZeneca, the Anglo-Swedish pharmaceutical group, suffered another setback when it suspended marketing of Iressa, a lung cancer drug launched this year.
134401
A drug currently prescribed to combat advanced breast cancer can now be used to help prevent the disease from recurring in women who have been treated for early forms of the disease, the US Food and Drug Administration ruled Friday.
112717
The US Food and Drug Administration Friday said it had approved Tarceva (erlotinib) tablets for patients with metastatic lung cancer.
426995
AstraZeneca Plc suffered its third  setback in two months on Friday as lung cancer drug Iressa  failed to help patients live longer in a major clinical trial,  sending its shares down more than 8 percent.
569835
The F.D.A. said that it would consider whether to remove Iressa, a product from AstraZeneca, from the market after the drug failed to prolong the lives of people in a clinical trial.
56445
WEDNESDAY, Jan. 16 (HealthDay News) -- A new genetic test that helps assess the risk of tumor recurrence and long-term survival for patients with relatively high-risk breast cancer has been approved by the U.S. Food and Drug Administration.
262304
Shares of Genentech Inc. DNA.N, OSI  Pharmaceuticals Inc. OSIP.O and ImClone Systems Inc. IMCL.O  surged before the bell on Friday after rival AstraZeneca Plc  AZN.L said its lung cancer drug Iressa failed to show  survival benefits in a major clinical study.
332200
Red wine, but no other form of alcohol, appears protective against lung cancer in men. A team of researchers in Spain has been comparing the lifestyles of 132 patients with lung cancer and 187 patients requiring minor surgery at the same hospital.
170594
Nov. 2,2004 - The Food and Drug Administration today warned consumers not to purchase or consume Actra-Rx or Yilishen, two products promoted for sale on Web sites as &quot;dietary supplements&quot; for treating erectile
602931
US drug regulators approved Tuesday the targeted anti-cancer treatment Tykerb (lapatinib) for use together with another drug, Xeloda (capectabine) in certain advanced breast cancers.
643182
NEW YORK - Last night, the US Food and Drug Administration approved Tarceva, a pill that extends survival in advanced non-small-cell lung cancer patients for whom chemotherapy has failed.
154392
A drug that helps the immune system attack lung cancer cells may improve survival time.
740280
The Food and Drug Administration approved a cancer drug made by pharmaceutical giant Eli Lilly and Co. to treat advanced non-small cell lung cancer in patients who have undergone chemotherapy.
609109
FRIDAY, Sept. 14 (HealthDay News) -- The Eli Lilly drug Evista (raloxifene) has been approved by the U.S. Food and Drug Administration to reduce the risk of invasive breast cancer among postmenopausal at high risk for the disease and among postmenopausal women with osteoporosis.
510674
NEW YORK, November 19  - Tarceva, an experimental lung cancer drug, has been approved by the Food &amp; Drug Administration, Genentech (DNA.